ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DEMG Deltex Medical Group Plc

0.135
0.005 (3.85%)
Last Updated: 09:18:03
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.005 3.85% 0.135 0.13 0.14 0.135 0.13 0.13 130,555 09:18:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electromedical Apparatus 2.48M -1.15M -0.0006 -2.17 2.4M
Deltex Medical Group Plc is listed in the Electromedical Apparatus sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 0.13p. Over the last year, Deltex Medical shares have traded in a share price range of 0.095p to 1.55p.

Deltex Medical currently has 1,846,653,348 shares in issue. The market capitalisation of Deltex Medical is £2.40 million. Deltex Medical has a price to earnings ratio (PE ratio) of -2.17.

Deltex Medical Share Discussion Threads

Showing 19651 to 19674 of 22675 messages
Chat Pages: Latest  787  786  785  784  783  782  781  780  779  778  777  776  Older
DateSubjectAuthorDiscuss
31/7/2018
13:15
Adjective department or adjectives' department, but not adjectives departmentI think
mrc2u
31/7/2018
10:52
I take it some posting here never sold at the chart high pointy bits

I understand your angst however a girl at school told me once

'' using bad language and/or swear words showed a lack of command of the English vocabulary , especially in the adjectives department ''

She was 13 yrs old at the time,
but I was very impressed non the less

buywell3
30/7/2018
23:37
Not the same, but the genesis was written large..
maxk
30/7/2018
13:28
Buywell old boyCan't you read the announcement that gives you the answer to who the seller is?Go on, give it a go. It will stop you wasting your time tooLet me know if you need any more cluesMrC
mrc2u
30/7/2018
11:14
other views might be

Who is the seller ?

or

Who are the sellers ?

How deep are the BoD's pockets to keep soaking up the share sales ?

buywell3
30/7/2018
10:17
"purchased" 2,234,222 ordinary shares
maxk
30/7/2018
10:01
Nice to see another director stepping up to the plate.......
chrisdgb
30/7/2018
09:52
buywell3 (9451): I note the DEMG Chart hook is now in

"Chart hook" ? What piece of charting lore is this?

arf dysg
30/7/2018
09:50
mrC2u, you might have a point. Maaaaaaaaaybe.
arf dysg
28/7/2018
10:59
I note the DEMG Chart hook is now in

(See top RHS chart on thread header)

Re recent keen buys at sub a penny , I wonder who has been selling ?

And how big was the queue of buyers ?

buywell3
27/7/2018
17:52
Only one o in no though
mrc2u
27/7/2018
15:43
No, no, no, no, no, no, noooooooooooo ooooooooo oooooooooo ooooooooooooooo ooooooooooo oooooooooooooooooooooo ooooooooo ooooooooooooooooooooooo ooooooooo oooooooooooo ooooooo!
arf dysg
27/7/2018
15:36
Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), was informed yesterday that Nigel Keen, Chairman of the Company, purchased 6,000,000 ordinary shares of 1 pence each in the Company...



No! No, no, no, no, no, no, nooooooooooooooooooooooooooooooooooooooooooooo!

The word "pence" is plural!!

Look at the writing on one of those small coins you have ... it's ONE PENNY

PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY PENNY !!!!!!!!!!!!!!!!!!!!!!!!


It should be "ordinary shares of ONE PENNY" !!!!!!!!!



I think I need to lie down in a dark room.

arf dysg
27/7/2018
11:16
Averaging down as trading deteriorates and the share price chart of a company falls like a brick

ie '' catching a falling knife'' is not considered a clever strategy by most clued up investors.

26 FEB 2016
Nigel John Keen
NON-EXECUTIVE DIRECTOR,CHAIRMAN
12,500,000 0.04 500.00 k

Purchase
10 JUN 2014
Nigel John Keen
NON-EXECUTIVE DIRECTOR,CHAIRMAN
1,363,636 0.11 150.00 k


Purchase
23 JAN 2013
Nigel John Keen
NON-EXECUTIVE DIRECTOR,CHAIRMAN
789,000 0.19 149.91 k

Purchase
30 OCT 2009
Nigel John Keen
NON-EXECUTIVE DIRECTOR,CHAIRMAN
1,066,666 0.09 96.00 k

Purchase
27 OCT 2005
Nigel John Keen
NON-EXECUTIVE DIRECTOR,CHAIRMAN
263,158 0.19 50.66 k


fair play to him , he keeps on doing it




The Bottom Line
Averaging down is a viable investment strategy for stocks, mutual funds and exchange-traded funds. However, due care must be exercised in deciding which positions to average down. The strategy is best restricted to blue chips that satisfy stringent selection criteria such as a long-term track record, minimal debt and solid cash flows.







I thus draw the obvious conclusion

buywell3
27/7/2018
11:07
Well, fair play to a £50,000 share purchase........
chrisdgb
26/7/2018
14:07
IMO DEMG is now in the A&E on life support

The question is how long before the equipment rendering same be left switched on ?

buywell3
26/7/2018
11:05
catch007

The problem is that until you run something like this for a lot of years, nobody will be able to predict whether it will be viable or not, as its subject to years of gaining approvals, tests etc. etc. Then you have to wait to find out whether all that effort actually gives you repeat sales or not.

My main objection to the board is not that they've run it wrongly, which is an easy criticism given the situation (so who would run it better and why, because you can't force the market imo), but that they've not been clear with investors about the reasons for lack of growth in the US. Which is even now making it difficult to make any judgement, even for a new investor who fancies a dabble.

Specifically, DEMG had a good chunk of revenue ages ago from the very first US hospitals, which has not significantly increased with all the new additions.

So the AGM question is: what on earth is different about all the additional hospitals, compared to the originals. Anyone can look back and see that initial US revenue and make the comparison.

yump
25/7/2018
15:25
Hey! There are some ABSOLUTELY MASSIVE companies in the footsie with about a billion shares!
arf dysg
25/7/2018
14:08
FWIW

With the current share price now sub one penny and with many annual cash raising events behind it , going back years

It is only the olde bull brigade with shares garnered at 30p or so , that never sold , that still believe and buy today.

Another loss of $2M looks very likely

Therefore the 1M cash left will need replacing in around 6 months

With falling sales everywhere , and the share price approaching 0.8p , the next raise price would surely have to be 0.5p

Which means to raise £2M ... to give this a chance to live another 12 months

ie Another 400 Million shares sold , and with loan notes , the Billion shares mark gets hit

buywell3
25/7/2018
13:49
Generally its a mismanaged company with an inept over paid executive board trying to execute a continual groundhog day strategy that fails every time as the cost of sales creates recurring and increasing losses. The targeted market isn't buying in the volumes needed nor is there sufficient profit per unit for a sustainable business model. A case study on how not to run a business IMHO!
catch007
25/7/2018
13:39
Re the phrase '' together with changes in ordering by two large accounts, ''


IMO I think this should have read ''together with losing two large accounts, ''

time will tell to who
dyor

buywell3
25/7/2018
13:35
Aortech about to go into orbit
hxxps://www.share-talk.com/share-news/share-talk-bulletin-board-heroes-25th-july-2018/

davisc7
25/7/2018
13:29
Well I'm sure some people partly bought in (me included) not because it looked like a road to riches, but because it seemed it might be a UK success story, as well as having a defendable niche and potential for good growth. For me, that was despite knowing that launching a medical device in general is a long drawn out and expensive process. Out of all the wonder-cures, medical stuff, it seemed that is was (just !!) a question of building up the users and then getting the holy-grail of repeat probe sales with little attached cost.

Unfortunately it appears to be just like a commodity sale - you have to keep banging away at the sales process and not much of the purchasing is routine.

I suppose it could just be that they've been unlucky recently with the changes in the US orders, but if ODM was firmly entrenched in the US hospital systems, there wouldn't be any changed orders.

That part has never been fully explained.

Perhaps a question to ask:
What percentage of sales is dependent on DEMG OGM being routinely specified and what percentage is dependent on repeat sales effort. If DEMG don't know that statistic they really need a lot of heads to roll.

Because the entire viability of the business depends on that.

yump
25/7/2018
12:46
This would seem to be pretty much the end of the journey. So many years of dwindling hopes. The value of my investment is now paltry but I won't sell out as I've somehow become sentimentally attached to it (why do we do this?)
eclair
Chat Pages: Latest  787  786  785  784  783  782  781  780  779  778  777  776  Older

Your Recent History

Delayed Upgrade Clock